Guardian Health
Drug that delays onset of type 1 diabetes approved in England and Wales
England and Wales will become among the first countries to offer teplizumab on the NHS, a drug that can delay the onset of type 1 diabetes by up to three years. The treatment works by slowing the immune system's destruction of insulin-producing cells, buying critical time before the disease fully takes hold. Experts are calling it the most significant advance in type 1 diabetes care in over a century.
Read article →KFF Health News
Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays
Medicare's pilot program using AI to manage prior authorizations is drawing sharp criticism from physicians and patients, who describe a system plagued by errors and bureaucratic delays. While federal officials tout the technology as a tool to curb fraud and control costs, frontline accounts paint a far messier reality. The trial raises urgent questions about whether AI is ready to act as a gatekeeper for critical medical decisions.
Read article →
Stat News
STAT+: Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?
Eli Lilly and the FDA granted a 79-year-old patient rare compassionate use access to an experimental obesity drug, bypassing the standard approval process. The case highlights how the agency's expanded access program can open doors to cutting-edge treatments for individuals outside typical clinical trial parameters. The identity of the patient, revealed exclusively by STAT, raises questions about who qualifies for such extraordinary pharmaceutical exceptions.
Read article →Medical Xpress
Faster aging in younger generations linked to rise in early-onset cancer
Biological aging appears to be accelerating in younger generations, with researchers linking faster cellular deterioration to the surge in early-onset cancers now being diagnosed in adults under 50. Unlike chronological age, biological age reflects the actual wear on cells and tissues — and mounting evidence suggests this wear is accumulating more rapidly in millennials and Gen Z than in previous generations. The finding reframes early-onset cancer not as a statistical anomaly but as a systemic generational health shift demanding urgent investigation.
Read article →Medical Xpress
AI tool reveals hidden organ damage caused by high blood pressure
A team at the University of Oxford has developed an AI tool capable of detecting how high blood pressure damages organs in ways that vary significantly between individuals. The findings, published in *Circulation*, could give clinicians a far clearer picture of hypertension's hidden toll on the body. The advance sets the stage for more targeted, personalized treatment strategies for the millions affected by the condition.
Read article →Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →